Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 2,041 - 2,060 results of 12,928 for search '(( significant ((step decrease) OR (teer decrease)) ) OR ( significantly increased decrease ))', query time: 0.50s Refine Results
  1. 2041
    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…While multi-VOC imaging methods have the potential to facilitate step-by-step metabolic tracking and improve disease screening accuracy, no such system currently exists. …”
    Save to List
    Saved in:
  2. 2042
    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…While multi-VOC imaging methods have the potential to facilitate step-by-step metabolic tracking and improve disease screening accuracy, no such system currently exists. …”
    Save to List
    Saved in:
  3. 2043
    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…While multi-VOC imaging methods have the potential to facilitate step-by-step metabolic tracking and improve disease screening accuracy, no such system currently exists. …”
    Save to List
    Saved in:
  4. 2044
    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…While multi-VOC imaging methods have the potential to facilitate step-by-step metabolic tracking and improve disease screening accuracy, no such system currently exists. …”
    Save to List
    Saved in:
  5. 2045
    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…While multi-VOC imaging methods have the potential to facilitate step-by-step metabolic tracking and improve disease screening accuracy, no such system currently exists. …”
    Save to List
    Saved in:
  6. 2046
    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…While multi-VOC imaging methods have the potential to facilitate step-by-step metabolic tracking and improve disease screening accuracy, no such system currently exists. …”
    Save to List
    Saved in:
  7. 2047
    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…While multi-VOC imaging methods have the potential to facilitate step-by-step metabolic tracking and improve disease screening accuracy, no such system currently exists. …”
    Save to List
    Saved in:
  8. 2048
    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…While multi-VOC imaging methods have the potential to facilitate step-by-step metabolic tracking and improve disease screening accuracy, no such system currently exists. …”
    Save to List
    Saved in:
  9. 2049
    Baseline and post-treatment results of categorical electrocardiographic variables in each study group.

    Baseline and post-treatment results of categorical electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2050
    Line graph showing the values of inflammatory cytokines at baseline and after treatment.

    Line graph showing the values of inflammatory cytokines at baseline and after treatment. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2051
    Baseline and Post-Treatment Myocardial Perfusion Defects Expressed as a Percentage of the Total Left Ventricular Surface Area in Each Experimental Group.

    Baseline and Post-Treatment Myocardial Perfusion Defects Expressed as a Percentage of the Total Left Ventricular Surface Area in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2052
    Baseline and post-treatment results of quantitative electrocardiographic variables in each study group.

    Baseline and post-treatment results of quantitative electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2053
    CONSORT diagram illustrating patient flow during the study.

    CONSORT diagram illustrating patient flow during the study. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2054
    Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.

    Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2055
    Illustrative images of the processing of a myocardial perfusion study in a patient with Chagas disease.

    Illustrative images of the processing of a myocardial perfusion study in a patient with Chagas disease. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2056
    Clinical and Demographic Characteristics of the Study Population.

    Clinical and Demographic Characteristics of the Study Population. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2057
    Illustrative images of the quantitative processing of polar maps from a myocardial perfusion study in one of the investigated patients.

    Illustrative images of the quantitative processing of polar maps from a myocardial perfusion study in one of the investigated patients. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2058
    Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.

    Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2059
    Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.

    Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 2060
    Variables obtained from the SF-36 quality of life questionnaire in each experimental group.

    Variables obtained from the SF-36 quality of life questionnaire in each experimental group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: